Clinical trials
Astrocytoma trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 10 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 7 |
| Novartis Pharmaceuticals | 6 |
| Nationwide Children's Hospital | 3 |
| Isarna Therapeutics GmbH | 2 |
| Jasper Gerritsen | 2 |
| Ludwig-Maximilians - University of Munich | 2 |
| AstraZeneca | 1 |
| Erasmus Medical Center | 1 |
| Heidelberg University | 1 |
| INSYS Therapeutics Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astrocytoma | 37 |
| Glioblastoma | 24 |
| Glioma | 21 |
| Brain Neoplasms | 12 |
| Oligodendroglioma | 12 |
| Central Nervous System Neoplasms | 7 |
| Diffuse Intrinsic Pontine Glioma | 6 |
| Neoplasms | 3 |
| Ganglioglioma | 2 |
| Ganglioneuroma | 2 |
Trials
Showing 26 to 37 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.